General Information of MET (ID: META00282)
Name Cholic acid
Synonyms   Click to Show/Hide Synonyms of This Metabolite
(3a,5b,7a,12a)-3,7,12-Trihydroxycholan-24-Oate; (3a,5b,7a,12a)-3,7,12-Trihydroxycholan-24-Oic acid; (3alpha,5beta,7alpha,12alpha)-3,7,12-Trihydroxycholan-24-Oic acid; 17b-[1-Methyl-3-carboxypropyl]etiocholane-3a,7a,12a-triol; 3a,7a,12a-Trihydroxy-5b-cholan-24-Oate; 3a,7a,12a-Trihydroxy-5b-cholan-24-Oic acid; 3a,7a,12a-Trihydroxy-5b-cholanate; 3a,7a,12a-Trihydroxy-5b-cholanoate; 3a,7a,12a-Trihydroxy-5b-cholanoic acid; 3a,7a,12a-Trihydroxy-b-cholanate; 3a,7a,12a-Trihydroxy-b-cholanic acid; 3a,7a,12a-Trihydroxy-beta-cholanate; 3a,7a,12a-Trihydroxy-beta-cholanic acid; 3a,7a,12a-Trihydroxycholanate; 3a,7a,12a-Trihydroxycholanic acid; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanate; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanic acid; 5b-Cholanic acid-3a,7a,12a-triol; 5b-Cholate; 5b-Cholic acid; Acid, cholic; Allocholate; Cholalate; Cholalic acid; Cholalin; Cholate; Cholic acid; Cholsaeure; Colalin
Source Endogenous;Escherichia Coli Metabolite;Sterol lipids;Food;Drug;Toxins/Pollutant;Food additives;TCM Ingredients;Microbial
Structure Type   Bile acids, alcohols and derivatives  (Click to Show/Hide the Complete Structure Type Hierarchy)
Lipids and lipid-like molecules
Steroids and steroid derivatives
Bile acids, alcohols and derivatives
PubChem CID
221493
HMDB ID
HMDB0000619
Formula
C24H40O5
Structure
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=221493"></iframe>
3D MOL 2D MOL
  Click to Show/Hide the Molecular/Functional Data (External Links/Property/Function) of This Metabolite
KEGG ID
C00695
DrugBank ID
DB02659
ChEBI ID
16359
FooDB ID
FDB012810
ChemSpider ID
192176
METLIN ID
206
Physicochemical Properties Molecular Weight 408.6 Topological Polar Surface Area 98
XlogP 3.6 Complexity 637
Heavy Atom Count 29 Rotatable Bond Count 4
Hydrogen Bond Donor Count 4 Hydrogen Bond Acceptor Count 5
Function
Cholic acid is a major primary bile acid produced in the liver and is usually conjugated with glycine or taurine. It facilitates fat absorption and cholesterol excretion. Bile acids are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, and depends only on the presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine, and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH, and consequently require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g. membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues. When present in sufficiently high levels, cholic acid can act as a hepatotoxin and a metabotoxin. A hepatotoxin causes damage to the liver or liver cells. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Among the primary bile acids, cholic acid is considered to be the least hepatotoxic while deoxycholic acid is the most hepatoxic. The liver toxicity of bile acids appears to be due to their ability to peroxidate lipids and to lyse liver cells. Chronically high levels of cholic acid are associated with familial hypercholanemia. In hypercholanemia, bile acids, including cholic acid, are elevated in the blood. This disease causes liver damage, extensive itching, poor fat absorption, and can lead to rickets due to lack of calcium in bones. The deficiency of normal bile acids in the intestines results in a deficiency of vitamin K, which also adversely affects clotting of the blood. The bile acid ursodiol (ursodeoxycholic acid) can improve symptoms associated with familial hypercholanemia.
Regulatory Network
Full List of Protein(s) Regulating This Metabolite
      Fatty acid transporter (FAT)
            Solute carrier family 27 member 5 (SLC27A5) Click to Show/Hide the Full List of Regulating Pair(s):   1 Pair(s)
               Detailed Information Protein   Info click to show the details of this protein
               Regulating Pair Experim Info click to show the details of experiment for validating this pair [1]
                      Introduced Variation Knockdown (shRNA) of Slc27a5
                      Induced Change Cholic acid concentration: decrease
                      Summary Introduced Variation         Induced Change 
                      Disease Status Healthy individual
                      Details It is reported that knockdown of Slc27a5 leads to the decrease of cholic acid levels compared with control group.
      GPCR secretin (GPCR-2)
            Glucagon receptor (GCGR) Click to Show/Hide the Full List of Regulating Pair(s):   1 Pair(s)
               Detailed Information Protein   Info click to show the details of this protein
               Regulating Pair Experim Info click to show the details of experiment for validating this pair [2]
                      Introduced Variation Knockout of Gcgr
                      Induced Change Cholic acid concentration: increase (FC = 244.30)
                      Summary Introduced Variation         Induced Change 
                      Disease Status Type 2 diabetes mellitus [ICD-11: 5A11]
                      Details It is reported that knockout of GCGR leads to the increase of cholic acid levels compared with control group.
      Nuclear hormone receptor (NHR)
            PPAR-alpha (PPARA) Click to Show/Hide the Full List of Regulating Pair(s):   1 Pair(s)
               Detailed Information Protein   Info click to show the details of this protein
               Regulating Pair Experim Info click to show the details of experiment for validating this pair [3]
                      Introduced Variation Knockout of Ppara
                      Induced Change Cholic acid concentration: increase
                      Summary Introduced Variation         Induced Change 
                      Disease Status Healthy individual
                      Details It is reported that knockout of Ppara leads to the increase of cholic acid levels compared with control group.
References
1 Attenuation of Slc27a5 gene expression followed by LC-MS measurement of bile acid reconjugation using metabolomics and a stable isotope tracer strategy. J Proteome Res. 2011 Oct 7;10(10):4683-91.
2 Polyomic profiling reveals significant hepatic metabolic alterations in glucagon-receptor (GCGR) knockout mice: implications on anti-glucagon therapies for diabetes. BMC Genomics. 2011 Jun 1;12:281.
3 Targeted Metabolomics Reveals a Protective Role for Basal PPAR in Cholestasis Induced by -Naphthylisothiocyanate. J Proteome Res. 2018 Apr 6;17(4):1500-1508.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.